Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727399 | PMC |
http://dx.doi.org/10.3389/fcimb.2022.1093692 | DOI Listing |
Neuromuscul Disord
January 2025
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Clinical trial readiness is an important topic in the field of facioscapulohumeral muscular dystrophy (FSHD). As FSHD is a slowly progressive and clinically heterogeneous disease, imaging biomarkers have been proposed to complement clinical outcome measures. Muscle magnetic resonance imaging (MRI), ultrasound and dual energy X-ray absorptiometry (DEXA) have been used to measure disease severity, activity and progression.
View Article and Find Full Text PDFJ Nucl Med
January 2025
Department of Nuclear Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China
Eur Respir J
January 2025
Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France.
J Clin Endocrinol Metab
January 2025
Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of San Francisco, CA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!